Lupin Posts Net Profit Of ₹130 Crore In Q2: Deven Choksey's Take On Pharma Stocks | CNBC-TV18

Lupin Posts Net Profit Of ₹130 Crore In Q2: Deven Choksey's Take On Pharma Stocks | CNBC-TV18Подробнее

Lupin Q4FY23 Earnings Tomorrow: Here are key expectations | NSE Closing Bell |CNBC-TV18Подробнее

Tech Mahindra's Q2 Net Profit Falls 4% To ₹1,285 Crore; Sun Pharma's Q2 Net Profit Up 11%Подробнее

Lupin's Management Talks About The Company's Q2FY Results | Halftime Report | CNBC-TV18Подробнее

Deven Choksey Shares His Views On The Current Market Rally | NSE Closing Bell | CNBC-TV18Подробнее

Deven Choksey Shares His Thoughts On Infosys Stocks & More | NSE Closing Bell | CNBC-TV18Подробнее

Stock Market Updates | Deven Choksey Shares His Views On Adani Ports | NSE Closing Bell | CNBC-TV18Подробнее

KRChoksey Group's Deven Choksey Speaks On His Top Stock & Sectoral Picks Of The Day | CNBC-TV18Подробнее

Lupin Mgmt on Weak Q3 Number | Co Q3 Nos fall to Rs 221.7 Cr. | CNBC TV18Подробнее

Deven Choksey Speaks On Latest Market Trends & Also Discusses Stocks | NSE Closing BellПодробнее

Stocks On The Move: Decoding Lupin's Q2FY23 Results | Bazaar Corporate Radar | CNBC-TV18Подробнее

What Are The Key Stocks & Sectors In Focus Today? | CNBC TV18Подробнее

Adani Ports Q3 Results: Profit Falls 16% YoY, Revenue Rises 17%: Deven Choksey ExclusiveПодробнее

KRChoksey Group's Deven Choksey's Top Stock & Sectoral Picks For Today | Bazaar Morning CallПодробнее

Lupin stumbles on Q2FY15 earnings: An interview with MD, Nilesh GuptaПодробнее

KRChoksey Group's Deven Choksey's Take On Q2FY23 Results Of Dr Lal PathLabs | Bazaar Morning CallПодробнее

Nilesh Gupta Of Lupin On Generic Pharma Market | CNBC-TV18Подробнее

KRChoksey Group's Deven Choksey On His Top Stock Picks For Today | Bazaar Morning Call | CNBC-TV18Подробнее

What Are The Top Stocks & Sectors In Focus Today? | CNBC TV18Подробнее

Lupin | The Stock on the Radar | Pharma Stock in Focus | CNBC TV18Подробнее